Addressing unmet needs for inherited neuromuscular diseases

Addressing unmet needs for inherited neuromuscular diseases
angilma1

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
arcticnovartis

Ad hoc announcement pursuant to Art. 53 LR